Vectors Research Management’s Chemours CC Stock Holding History

Vectors Research Management’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-260	Closed	-$8K	–	197
2022 Q2	$8K	Hold	260	–	–	﹤0.01%	388
2022 Q1	$8K	Sell	260 -35	-12%	-$1.09K	﹤0.01%	376
2021 Q4	$10K	Buy	295 +30	+11%	+$935	﹤0.01%	415
2021 Q3	$8K	Hold	265	–	–	﹤0.01%	385
2021 Q2	$9K	Hold	265	–	–	﹤0.01%	395
2021 Q1	$7K	Sell	265 -100	-27%	-$2.66K	﹤0.01%	359
2020 Q4	$9K	Buy	365 +90	+33%	+$2.14K	﹤0.01%	335
2020 Q3	$4K	Buy	275 +100	+57%	+$1.93K	﹤0.01%	347
2020 Q2	$3K	Hold	175	–	–	﹤0.01%	371
2020 Q1	$2K	Sell	175 -100	-36%	-$1.44K	﹤0.01%	420
2019 Q4	$5K	Buy	275 +100	+57%	+$1.66K	﹤0.01%	411
2019 Q3	$3K	Hold	175	–	–	﹤0.01%	399
2019 Q2	$4K	Hold	175	–	–	﹤0.01%	329
2019 Q1	$7K	Hold	175	–	–	﹤0.01%	301
2018 Q4	$5K	Sell	175 -90	-34%	-$2.85K	﹤0.01%	513
2018 Q3	$12K	Buy	+265	New	+$11.6K	0.01%	297

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vectors Research Management's CC Position: Q3 2022 in Review

Vectors Research Management sold out of Chemours (CC) in Q3 2022, closing a stake of 260 shares — an estimated $8K sold.

Vectors Research Management first reported a position in CC in Q3 2018 and held it in 16 quarters. The position peaked at $12K in Q3 2018. 487 funds tracked by Wall St. Rank hold CC as of Q3 2022.

Vectors Research Management reported no remaining Chemours position as of Q3 2022 after selling out during the quarter.
Vectors Research Management sold 260 Chemours shares in Q3 2022, an estimated $8K.
Vectors Research Management first reported a position in Chemours in Q3 2018 and held it in 16 quarters.
Vectors Research Management's Chemours position peaked at $12K in Q3 2018.
487 funds tracked by Wall St. Rank held Chemours as of Q3 2022.

Based on Vectors Research Management's 13F filing for Q3 2022, filed 8 Nov 2022.